-
FDA approves new GSK drug to treat HIV infection
WASHINGTON — The U.S. Food and Drug Administration on Monday approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection that is manufactured by GlaxoSmithKline.
Tivicay is an integrase strand transfer inhibitor that interferes with one of the enzymes necessary for HIV to multiply. It is a pill taken daily in combination with other antiretroviral drugs.
-
More than a dozen health information exchanges, service providers join Surescripts
ARLINGTON, Va. — Electronic prescribing network Surescripts has added 19 state health information exchanges and health information service providers to its network, the company said.
These include entities in Maryland, Ohio, Colorado, Michigan, New York, Tennessee and others.